Publication Name	World Journal of Diabetes
Manuscript ID	13483
Country	Canada

Received	2014-08-25 08:14
Peer-Review Started	2014-08-25 17:30
To Make the First Decision	2014-10-14 18:11
Return for Revision	2014-10-20 12:28
Revised	2014-11-14 10:37
Second Decision	2015-01-04 15:58
Accepted by Journal Editor-in-Chief	2015-01-05 10:56
Accepted by Company Editor-in-Chief	2015-01-12 14:32
Articles in Press	2015-01-12 14:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-03 17:54
Publish the Manuscript Online	2015-04-20 09:13

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	New-onset diabetes mellitus after kidney transplantation: Current status and future directions
Manuscript Source	Invited Manuscript
All Author List	Sneha Palepu and G V Ramesh Prasad
Funding Agency and Grant Number
Corresponding Author	G V Ramesh Prasad, MBBS, MSc, MA, FRCPC, FACP, FASN, Associate Professor of Medicine, Division of Nephrology, University of Toronto, St. Michael’s Hospital, 61 Queen Street East, 9th Floor, Toronto ON M5C 2T2, Canada. prasadr@smh.ca
Key Words	Cyclosporine; Graft; Kidney; New-onset diabetes; Tacrolimus; Transplantation
Core Tip	New-onset diabetes after kidney trans-plantation (NODAT) is detrimental to patient and graft survival. Early diagnosis through the identification of modifiable and non-modifiable risk factors for NODAT and appropriate screening, accompanied by good glycemic control that involves a multidisciplinary care approach will help result in good short- and long-term kidney transplant outcomes.
Publish Date	2015-04-20 09:13
Citation	Palepu S, Prasad GVR. New-onset diabetes mellitus after kidney transplantation: Current status and future directions. World J Diabetes 2015; 6(3): 445-455
URL	http://www.wjgnet.com/1948-9358/full/v6/i3/445.htm
DOI	http://dx.doi.org/10.4239/wjd.v6.i3.445

Full Article (PDF)	WJD-6-445.pdf
Full Article (Word)	WJD-6-445.doc
Manuscript File	13483-Review.docx
Answering Reviewers	13483-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	13483-Conflict-of-interest statement.pdf
Copyright License Agreement	13483-Copyright assignment.pdf
Peer-review Report	13483-Peer review(s).pdf
Scientific Misconduct Check	13483-CrossCheck.jpg
Scientific Editor Work List	13483-Scientific editor work list.pdf